Hormone Therapy for Women (HRT)
A monitored estrogen and progesterone program built from your labs and symptoms, with testosterone where appropriate.
- Hot flashes, night sweats and the sleep disruption that comes with them
- Mood, cognitive clarity and bone health through the transition
- Genitourinary comfort, where a local route is often added alongside a systemic one
A monitored program, not a prescription and silence. Symptom relief is the measure — not a lab value.
Indicative price · confirmed after eligibility · prescription treatment
What the program covers
If you were told years ago that hormone therapy carried serious risks — that it caused breast cancer, heart disease, dementia — you were told what the label said at the time.
That label changed in February 2026. The FDA approved labeling changes removing the boxed warnings on cardiovascular disease, breast cancer and probable dementia from menopausal hormone therapy products. The agency pointed to randomized evidence that women who start hormone therapy within roughly ten years of menopause show reduced all-cause mortality and fewer fractures.
For a great many women in their forties, fifties and sixties, that reopens a conversation they were told to stop having. This page is about what hormone therapy actually involves now, what it can and can't do, and how to decide whether it fits you.
Hormone therapy for women is a program rather than a single product. Your clinician chooses among estradiol delivery routes, progesterone, and — where appropriate — testosterone, then reviews your response over time. Estrogen addresses vasomotor symptoms (hot flashes, night sweats), sleep disruption, mood and cognitive clarity, bone health and genitourinary comfort. Progesterone is included for women with a uterus, to protect the uterine lining from unopposed estrogen; it also has effects some women notice on sleep, and it isn't optional where it applies. Testosterone is sometimes considered for energy, strength and libido — added only where appropriate and monitored, and more commonly relevant in midlife women than most people expect.
How it works here
Every plan follows one path. Each step feeds the next. See the Women's Hormone Therapy approach.
- 01
Measure
We baseline your labs, history, and goals.
- 02
Plan
A clinician decides whether this fits — and what else might serve you.
- 03
Act
If appropriate, you start with clear guidance and high-touch support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
What the label change does and doesn't mean
What it means: the warning that shaped two decades of advice — originating in the Women's Health Initiative results of the early 2000s — no longer appears on these products. Subsequent analysis showed the original findings were driven substantially by the age of the women studied, most of whom started therapy well after menopause. For women starting closer to the transition, the balance looks materially different.
What it doesn't mean: that hormone therapy is risk-free, or right for everyone. Risk still varies by your age, how long since menopause, your personal and family history, and which route you use. A personal history of breast cancer, blood clots or certain cardiovascular conditions still changes the answer.
What's changed is that the conversation can now be proportionate to the actual evidence, rather than shut down by a warning that applied a single blanket caution to every woman and every formulation. If you dismissed HRT years ago on the strength of that warning, it's worth revisiting with someone who can look at your specific history.
Why timing matters
The evidence points consistently in one direction: starting closer to the menopause transition tends to produce a better risk-benefit balance than starting many years later.
This is sometimes called the timing hypothesis, and it's the single most useful thing to understand when deciding whether to act. Waiting to see whether symptoms resolve on their own is a reasonable instinct — but for some symptoms, particularly genitourinary ones, they don't resolve, and the window in which starting is most favorable doesn't stay open indefinitely.
That isn't a reason to rush. It is a reason not to treat “I'll think about it for a few more years” as a neutral choice.
Choosing a delivery route
| Patch | Topical / Cream | Oral capsule | Vaginal (local) | |
|---|---|---|---|---|
| Available at ACT 2 | Yes | Yes | Yes | Yes |
| Treats whole-body symptoms | Yes | Yes | Yes | No — local only |
| Treats genitourinary symptoms | Partly | Partly | Partly | Yes — directly |
| How it's used | Worn and changed on a schedule | Applied to skin | Swallowed | Applied locally |
| Risk of transferring to others | Minimal | Yes — skin contact | None | Possible |
| Level pattern | Steadiest | Fairly steady | More variable | Local, minimal systemic |
| Convenience | Highest — set and forget | Daily routine | Daily routine | Ongoing |
| Best suited to | Women who want low maintenance | Women who prefer to control application | Women who prefer no skin application | Dryness, discomfort with sex, urinary symptoms |
Scroll the table sideways to compare →
The honest summary: route is a genuine clinical decision, not just preference — the routes don't behave identically, and your history influences which is more appropriate. But among reasonable options, the one you'll use consistently wins. Many women use a systemic route *and* a local one, which is a normal combination rather than doubling up.
Explore the individual options: estradiol topical, estradiol patch, estradiol cream, progesterone capsule, progesterone cream and estriol vaginal cream. Your clinician selects the specific preparation as part of your plan.
Who this isn't right for
Hormone therapy generally isn't appropriate with undiagnosed vaginal bleeding, active breast or endometrial cancer, active liver disease, or a history of certain blood clots or strokes. A personal history of breast cancer is a nuanced discussion increasingly held jointly with oncology rather than an automatic no — but it is a real conversation, not a formality.
Any bleeding after menopause needs evaluation, regardless of whether you're on hormone therapy. That's not a warning specific to HRT; it's true generally.
What ongoing care looks like
This is where a program differs from a prescription, and it's most of what you're paying for after the first visit.
Baseline: relevant hormone levels, thyroid function, a metabolic and lipid picture, iron status, plus a full history covering your symptoms, your family history and where you are in the transition.
Then review on a defined cadence. Symptom relief is the primary measure — not a lab value. The question is whether hot flashes have settled, whether you're sleeping, whether the fog has lifted. Adjustments over the first months are normal and expected rather than a sign something went wrong.
And a genuine reassessment over time, including whether to continue. Current guidance doesn't impose an arbitrary stop date, but it does support periodically revisiting the decision as your circumstances change.
Availability
Hormone therapy for women is available in all 50 states, delivered by telemedicine from clinicians licensed in the state where you're located. See where we're available.
Delivery
A clinician-led program; the delivery route (patch, cream, capsule) is chosen with your clinician and adjusted over time.
Is it right for you?
This fits women in perimenopause or menopause who want a measured, monitored plan rather than a prescription and silence. It's a particularly worthwhile conversation if you were advised against hormone therapy years ago and haven't revisited it since — the labeling that underpinned that advice has changed. If your symptoms are primarily genitourinary, estriol vaginal cream may be all you need. And if weight change is a major part of what you're experiencing, medical weight loss is worth reading alongside this, since the two interact more than either is usually discussed.
Often considered alongside
Estradiol (Clear)
CompoundedTopical estradiol that may help support relief from menopausal symptoms.
View treatmentProgesterone Capsule
CompoundedOral progesterone — endometrial protection alongside estrogen, and the route many women notice on sleep.
View treatmentEstriol Vaginal Cream
CompoundedTargeted estriol that may help support vaginal and genitourinary comfort.
View treatmentProducts marked Compounded are prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved and are not equivalent to or interchangeable with any branded product.
An honest word on the evidence
Modern hormone therapy is well studied, and current guidance supports it for many women when started within an appropriate window and matched to individual risk. Benefits and risks differ by age, history and route. Three things worth saying plainly. It isn't a cure for aging: hormone therapy treats the symptoms of hormonal change, it won't reverse everything that shifts in midlife, and anyone selling it as a whole-body reversal is overselling. It won't fix what isn't hormonal: thyroid dysfunction, iron deficiency, sleep apnea, depression and medication effects all produce symptoms that look like menopause, which is why we measure first — sometimes the more useful outcome is discovering the cause is something else entirely. And perimenopause is genuinely harder to measure than menopause: hormones fluctuate substantially during the transition, so a single blood draw can look unremarkable on a day when you feel awful. Your clinician reads labs alongside your symptom pattern rather than treating one number as the verdict. See menopause and perimenopause care.
References
Government and professional-society sources consulted for this page.
- Estrogen and Progestin (Hormone Replacement Therapy) — MedlinePlus (U.S. National Library of Medicine)
- Hormone Therapy for Menopause — American College of Obstetricians and Gynecologists
- The Menopause Years — American College of Obstetricians and Gynecologists
- Menopause — MedlinePlus (U.S. National Library of Medicine)
Frequently asked questions
That warning was removed. In February 2026 the FDA approved labeling changes removing the boxed warnings on cardiovascular disease, breast cancer and probable dementia from menopausal hormone therapy products, citing evidence that women starting within about ten years of menopause showed reduced all-cause mortality and fewer fractures. Risk still varies by your history and route, but the blanket warning that shaped two decades of advice no longer stands.
That depends on how long it's been since menopause and on your history. Evidence suggests starting closer to the transition produces a better balance than starting many years later. It's a genuine clinical conversation rather than a fixed cutoff.
That's chosen with your clinician based on your symptoms, history and preference — patch, cream and capsule each behave differently. Among reasonable options, consistency matters most.
If you have a uterus, yes. Progesterone protects the uterine lining from unopposed estrogen. It isn't optional where it applies.
Your first visit covers the fuller workup and plan build. Refills cover ongoing medication and monitoring once you're established.
Sometimes it's considered for energy, strength and libido. It's added only where appropriate and monitored — and it's relevant more often in midlife women than most people assume.
Vasomotor symptoms often respond within weeks; sleep and mood can take longer. Adjustments over the first few months are normal rather than a sign of failure.
There's no arbitrary stop date in current guidance, but the decision is revisited periodically as your circumstances change. Ongoing rather than indefinite-by-default.
Possibly. Hormones fluctuate substantially in perimenopause, so a single draw can look unremarkable on a bad day. Your clinician reads labs alongside your symptom pattern rather than treating one number as the verdict.
Yes — hormone therapy for women is available in all 50 states, delivered by telemedicine from a clinician licensed where you're located.
See if Hormone Therapy for Women (HRT) fits your plan
The right plan begins with knowing where you are. Start with a short eligibility check and a baseline — and we'll tell you, honestly, what fits.
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.